Main Street Financial Solutions’s Acceleron Pharma XLRN Stock Holding History

Main Street Financial Solutions’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,003	Closed	-$517K	–	501
2021 Q3	$517K	Hold	3,003	–	–	0.08%	246
2021 Q2	$377K	Buy	3,003 +34	+1%	+$4.29K	0.06%	303
2021 Q1	$403K	Buy	2,969 +169	+6%	+$21.8K	0.07%	261
2020 Q4	$358K	Buy	+2,800	New	+$328K	0.07%	257

Main Street Financial Solutions's XLRN Position: Q4 2021 in Review

Main Street Financial Solutions sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,003 shares — an estimated $517K sold.

Main Street Financial Solutions first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $517K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Main Street Financial Solutions reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Main Street Financial Solutions sold 3,003 Acceleron Pharma shares in Q4 2021, an estimated $517K.
Main Street Financial Solutions first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
Main Street Financial Solutions's Acceleron Pharma position peaked at $517K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Main Street Financial Solutions's 13F filing for Q4 2021, filed 8 Feb 2022.